All J&J articles – Page 3

Feature

The hunt for innovation

2014-01-31T00:00:00Z

Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom

Business

Weathering the storm

2014-01-06T00:00:00Z

Pharmaceutical industry roundup 2013

Business

New wave of hepatitis C drugs hits US shore

2013-12-03T00:00:00Z

J&J’s once-daily drug approved by FDA, but rivals are hot on its heels

Business

Mis-selling lands J&J with $2.2bn fine

2013-11-11T00:00:00Z

Company found guilty of promoting three drugs for unapproved uses

Business

First biosimilar antibody drugs approved in Europe

2013-09-11T00:00:00Z

European commission gives final approval to generic infliximab copies

Business

J&J buys Aragon’s prostate cancer arm

2013-08-22T00:00:00Z

Hormone cancer specialist spins out other programmes before sale

Business

Biosimilar drugs step up complexity

2013-07-02T00:00:00Z

First generic monoclonal antibodies recommended for approval in Europe

Business

TB drug milestone for bedaquiline

2013-01-03T00:00:00Z

First TB drug with a new mechanism of action for 40 years wins approval

Business

Bapineuzunab dropped

2012-08-09T00:00:00Z

Development for the Alzheimer’s treatment stopped after clinical tests